NewsBites
简讯
monSanTo co. and bioSynTheTic
Technologies, llc recently signed
license and supply agreements that
will expand the market opportunity for
Vistive® gold soybean growers.
The collaboration creates an
opportunity for use of monsanto’s
Vistive® gold soybean oil in the
production of biosynthetic lubricating
oils.
“we have tested numerous feed
stocks as part of our ongoing research
and discovered excellent results using
high-oleic soybean oils, in particular
Vistive® gold,” said allen barbieri,
chief executive officer of biosynthetic
Technologies.
“This is an important collaboration
as we move forward with our other
global partners to launch their first lines
of domestically-sourced, renewable
biosynthetic lubricants. high-oleic
soybean oils are a cost-competitive
alternative to many of the feed stocks
we’ve explored, and working with
monsanto is a natural fit, given our
shared commitment to sustainability
and the potential for this product,” he
said.
Vistive® gold soybeans were
developed by monsanto to improve
soybean oil’s oxidative stability and
reduced saturated fat. This improved
oil provides benefits in both food and
industrial applications that are not
possible from commodity soybean oil.
under the terms of the
agreement, monsanto has made an
equity investment of uS$7 million
in biosynthetic Technologies. This
investment by monsanto, in addition
to investments from bp Ventures and
other investors, will enable biosynthetic
Technologies to finalize construction
of its pilot plant to facilitate continued
product development and support the
commercial launch of its products.
The company is in the final stages of
successful fleet testing and certification
of lubrigreen biosynthetic motor oils
synthesized from high-oleic oils, such
as Vistive® gold.
The u.S. department of agriculture
(uSda) deregulated the biotech trait
in Vistive® gold soybeans in december
2011, completing the u.S. regulatory
process and allowing field testing and
seed production to take place within
the united States.
monsanto, based in St. louis, mo.,
u.S.a., is a leading global provider
of technology-based solutions and
agricultural products that improve
farm productivity and food quality.
biosynthetic Technologies llc, based
in irvine, calif., u.S.a., holds exclusive
rights to patented technology that
converts fatty acids found in plant
and animal oils into high performance
synthetic lubricating base oils. These
“biosynthetic” base oils exhibit the
many superior characteristics of
petroleum-based lubricating oils.
孟山都与Biosynthetic Technologies,
LLC近期签订了技术许可和供货协议,将共
同为Vistive
®
Gold大豆的种植者提供市场
机遇。
此项合作将创造在合成润滑油的生产中
使用孟山都Vistive
®
Gold大豆油的机会。
“在研究中,我们对多种原料进行了试
验,发现采用含油量高的大豆油得到了非
常理想的结果,特别是Vistive
®
Gold,”
Biosynthetic Technologies的首席执行
官Allen Barbieri说。
“这是一项重要合作,我们将与其他全
球的合作伙伴推出他们第一个国内采购的、
可再生的生物合成润滑油产品系列。高油量
的大豆油比我们研究过的多种其他原料更
具成本竞争优势,鉴于我们对可持续性的共
同承诺,以及我们对这个产品的潜力的共同
认识,与孟山都的合作是一种自然结合。”
他说。
Vistive
®
Gold大豆由孟山都开发,提高
了大豆油的氧化稳定性并降低了饱和脂肪
的含量。这种改进的油为食用和工业应用
提供了普通大豆油所不具备的优点。
按照协议,孟山都对B i o s y n t h e t i c
Technologies进行了700万美元的股本
投资。除BP
Ventures和其他投资者以
外,孟山都的这项投资将使Biosynthetic
Technologies最终建成其中试装置以继续
产品开发并支持其产品的商业化。
公司正在进行从诸如Vistive
®
Gold这类
高含油油料合成的LubriGreen生物合成机
油的最终车队行车试验和认证。
美国农业部在2011年12月解除了对
Vistive
®
Gold大豆的生物技术特征限制,
完成了美国法规程序,并允许在美国境内进
行行车试验和种子生产。
总部位于美国密苏里州圣路易斯的孟
山都是一家全球领先的技术解决方案和
农业产品提供者,这些方案和技术提高了
农场的产量和食品质量。Biosynthetic
Technologies位于美国加州Irvine,拥有
把植物油脂和动物油脂中的脂肪酸转化为
高性能合成润滑基础油的专有权。这些“生
物合成”基础油显示出了优于石油基润滑油
所不具备的许多优异特性。
Monsanto and Biosynthetic
Technologies sign agreement
孟山都与Biosynthetic
Technologies签订协议
ACHIEVING
EFFICIENCY
THE ESSENTIAL AUTOMOTIVE TECHNOLOGY EVENT
April 16 -18, 2013
Cobo Center • Detroit, Michigan, USA
As we strive to achieve efficiency, the resulting significant
and exciting challenges are once again positioning the
automobile industry as the industry of choice for the world’s
best and brightest engineering minds. Vast opportunities
await those companies and individuals that dare to be
creative and dream big.
sae.org/congress
Host Company
Learn more!
Tier One
Strategic Partner
P126154
FUELS & LUBES INTERNATIONAL
Quarter One 2013
14
1...,4,5,6,7,8,9,10,11,12,13 15,16,17,18,19,20,21,22,23,24,...44